Terrance P. Coyne

EVP & CFO

Terrance P. Coyne (EVP & CFO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales, 1 filed past the two-business-day deadline), most often in Royalty Pharma plc (RPRX). The largest single filing was $10.3M of RPRX (242,454 sh across 5 lots, as filed), executed Feb 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells · 1 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$38.4M

shares × price, as filed

Last traded

Aug 13

Filed Aug 17

Median ADV $206.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $38.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

RPRX

Royalty Pharma plc RPRX · 0 buys · 14 sells 14 filings

Recent filings

RPRXSALE Royalty Pharma plc View filing → $646K
11,002 sh across 2 lots
Exec Aug 13
Filed Aug 17 · 5:01 PM ET RPRXSALE Royalty Pharma plc View filing → $3.5M
64,399 sh × $53.98
Exec May 26
Filed May 28 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $1.6M
32,916 sh × $49.78
Exec Apr 28
Filed Apr 30 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $1.6M
32,916 sh × $48.33
Exec Apr 1
Filed Apr 2 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $1.5M
32,916 sh × $45.53
Exec Mar 23
Filed Mar 25 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $1.5M
32,916 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $1.5M
32,916 sh × $45.32
Exec Feb 23
Filed Feb 25 · 5:30 PM ET RPRXSALE Royalty Pharma plc View filing → $10.3M
242,454 sh across 5 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET More filings →